Refine by
Drug Discovery Articles & Analysis: Older
381 news found
“Our diagnostic development services offer tailored solutions designed to accelerate the pace of discovery in rare disease research. By providing innovative diagnostic tools and support, we empower researchers to take significant steps toward effective ...
Alfa Chemistry provides a wide variety of these intermediates which meet strict quality and safety requirements required for the drug development process. These intermediates (ammonium acids, organic acids, esters and heterocyclic compounds) allow us to innovate in drug synthesis, which in turn leads to more effective and precise drugs. ...
Chronic Obstructive Pulmonary Disease (COPD) is a global health burden characterized by persistent airflow limitation and progressive lung damage. Despite extensive research, translating findings from bench to bedside remains a challenge. Precision Cut Lung Slices (PCLS) have emerged as a versatile tool in COPD research, offering unique advantages for understanding disease mechanisms and ...
Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality worldwide, ...
As an innovative ophthalmic disease research company with a wide range of services in basic research, drug development, and preclinical studies, Ace Therapeutics has expanded its portfolio to include gene therapy solutions designed specifically to accelerate glaucoma drug discovery and development. ...
In the ever-evolving landscape of pharmaceutical research and development, the demand for innovative and efficient drug discovery methods is more pressing than ever. At the forefront of this demanding field is Protheragen-ING AI-Pharma, a contract research and development biotechnology company, offering cutting-edge solutions to researchers through its ...
Protheragen-ING has recently announced its ability to provide freeze-drying flash-release formulation development services to clients involved in drug discovery and development worldwide. Lyophilized flash-release formulations are advanced drug delivery systems that incorporate the benefits of both lyophilization and flash-release technologies. ...
Kelly Bugatti, BOC Sciences is set to host an informative webinar that will delve into the latest advancements in utilizing Peptide-Drug Conjugates (PDCs) for the targeted treatment of Pulmonary Fibrosi BOC Sciences has been organizing regular webinars in the fields of life sciences, drug discovery, and chemistry. ...
It is a practical and effective tool for high-throughput molecular analysis of tissues, helping to identify new diagnostic and prognostic markers and targets for human cancers, with a wide range of potential applications in basic research, tumor prognosis and drug discovery. Immune System Tissue Microarrays from CD BioSciences are meticulously designed to feature ...
Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, animal models that closely mimic the human disease are crucial. ...
By leveraging its expertise and resources, the company can develop animal models, cell models, multicellular models, pharmacokinetic/pharmacodynamic modeling, biomarker discovery, and more. These model development services are designed to offer researchers the tools and resources they need to optimize drug development and maximize success rates. ...
The precise tissue dissociation guaranteed by this technology preserves cellular integrity, producing high-quality suspensions essential for a variety of applications, including regenerative medicine and drug discovery. Intrigued? Find out more in our first application note in the “Mastering Tissue Dissociation” series. ...
Following with the announcement of developing small molecule drug for glaucoma, Ace Therapeutics recently unveiled disease model customization services to accelerate further the preclinical research on gastroenterology (GI) and hepatology. ...
The applications of WGS are vast, impacting fields such as disease research, drug discovery, personalized medicine, food safety, agriculture, and pharmacy. Key advantages of WGS include single base-pair resolution, de novo sequencing and genome-wide mutation characterization, population evolution and phylogenetic studies, and its critical role in disease ...
CD ComputaBio, a pioneering provider of computational biology services, has recently introduced its advanced Computer-Aided Drug Design (CADD) services, revolutionizing the drug discovery landscape. ...
To date, 3D cell culture systems, including scaffold-based and scaffold-free, have been widely applied in differentiation studies, drug discovery, cancer research, gene and protein expression studies, and cellular physiological studies. ...
Overall, by broadening its supply of these essential ligands, Alfa Chemistry aims to support various research initiatives, from fundamental studies in coordination chemistry to applied research in drug discovery and materials science. "Our goal is to be a trusted partner for researchers worldwide," remarked the marketing director at Alfa Chemistry. ...
CanaQuest Medical Corp (“CanaQuest” or the “Company”) (OTC: CANQF), is pleased to announce strategic additions to its executive team with expertise in conducting clinical trials and US FDA drug approval success. The team plans to effectively navigate the regulatory approval process for Drug Candidate, CQ-001 (cannabidiol + proprietary API composition), to treat rare ...
Stem cells have revolutionized cell-based therapeutics, drug discovery and many other scientific fields. However, despite significant advancements in iPSC culture, several challenges remain regarding the reliability, reproducibility and consistency of cell cultures, assays and data. ...
[Philadelphia, May 7-9, 2024] - Protheragen-ING, a pharmaceutical products supplier focused on innovative drug discovery and development, is pleased to announce its participation in the highly anticipated 2024 CPHI North America Conference. ...